New

Trackinsight Enterprise, a unified platform for institutional ETF research, analytics, and compliance, is now live. Explore Trackinsight Enterprise →

Help us improve your experience. Please confirm your investor type:

ETF What's Up

Don’t Miss a Move in the ETF Market

Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.

ETF What's Up

You may unsubscribe at any time by clicking the “unsubscribe” link within the emailed newsletter. By signing up, you agree to our Privacy Policy and Terms and Conditions.

ETF screener

BBP ETF · Virtus LifeSci Biotech Products ETF

The BBP Exchange Traded Fund (ETF) is provided by VIRTUS Investment Partners. It is built to track an index: LifeSci Biotechnology Products Index. The BBP ETF provides physical exposure, so by buying it you actually own parts of all the 59 underlying holdings. This share class generates a stream of income by distributing dividends.
Last update Today at 1:30 PM UTC
LIVE
CLOSED
This fund is part ofTomorrow's Treatments1M perf.-1.29%
Last price
$88.06
1M perf.
-1.38%
1M flows
+€3.7M
AuM
€68M
TER
0.79%
Rating
ESG Consensus®
esg grade icon
BBP
$88.06

Performance & flows

Segment for quartile rank
March 12, 2026 → June 12, 2026
0-4%-2%0%2%4%6%8%10%12%APRMAYJUNAPRMAYJUN
Create a free account to view the flows graph
BBP
$87.14
+7.00%
Tomorrow's Treatments
+3.69%

Historic performance and flows

1M3M1Y3Y5YMTDQTDYTD
Perf.
-1.38%
icon
+7.00%
icon
+43.65%
icon
+60.05%
+58.90%
+0.65%
+4.36%
+9.25%
icon
Flows

Key fund info

Segment for quartile rank
This ETF's jurisdiction country is not in your region (Europe and Middle East) · 
Main characteristics
CUSIP
26923G202
ISIN
US26923G2021
AuM
€68M
icon
TER
0.79%
icon
Replication rating
ESG Consensus®
esg grade icon
More details
NAV
6/12/2026
$87.14
1D NAV change
+0.37%
Dividend policy
Replication method
Direct (Physical)
Replication model
Full replication
No. of holdings
59
Inception date
12/16/2014
Jurisdiction
United States
Distribution
United States
Legal structure
Statutory Trust
Base currency
USD
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Product type
Asset class
Factors
N/A
Investment strategy
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index, which tracks the performance of biotechnology companies with at least one drug therapy approved by the FDA.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
half moonhalf moon double
New to Trackinsight?
For individual investors

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.
More fund data
Compare up to 3 funds
More screener filters
Choose your own screener columns from 100+ metrics
Lists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring
For professional investors

Trackinsight
Enterprise

Trackinsight Enterprise addresses the everyday operational, regulatory, and analytical pain points faced by professional and institutional ETF investors, from selection to execution.
Request a free trial
More professional services:ETF Data ServicesDue Diligence Services

Similar ETFs in your region

XBI
1M perf.
-0.89%
TER
0.35%
CURE
1M perf.
+2.29%
TER
0.45%
XHE
1M perf.
+4.32%
TER
0.35%
PSCH
1M perf.
+6.00%
TER
0.29%
ARKG
1M perf.
+12.70%
TER
0.75%

Advertisement

Risk profile

Segment for quartile rank

Historical risk/return profile

3M1Y3Y5Y
Returns
+7.00%
icon
+43.65%
icon
+60.05%
+58.90%
Volatility
Perf./Volatility
Max drawdown
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
More exposure metrics are available, exclusively in Trackinsight Enterprise

Exposure

Countries
USA
84.13%
United Kingdom
3.17%
Canada
3.12%
Cayman Islands
2.80%
Switzerland
2.72%
Unavailable
4.05%
Sectors
Health Care
85.97%
Unavailable
14.03%
Diversification
Total weight of top 15 holdings out of 59
More risk metrics are available, exclusively in Trackinsight Enterprise

Sustainability

Integrates ESG criteria
No
SDG

ESG Consensus® by Conser

Data as of April 30, 2026
Methodology

Our partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about BBP ETF's sustainability, based on their methodology.

Learn more about Conser

ESG Consensus®
esg grade icon

ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.


BBP’s has a Final Sustainability Grade of either A+, A, or A-.

This fund’s exact Final Sustainability Grade is available in Trackinsight Enterprise.
Learn more about Trackinsight Enterprise
Holdings review
101.46% of holdings have positive scoring
2.76% of holdings have negative scoring
75.28%
22.77%
Consensus levels
Strong
Medium
Weak
More sustainability metrics are available, exclusively in Trackinsight Enterprise

Replication

Trackinsight replication rating:
1-year trailing difference
As of May 29, 2026
Create a free account to view the replication graph
BBP
N/A
Replication quality
Calculated over 12m, as of May 29, 2026
Tracking error
Tracking difference
1-year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Replication information
Index
Index ticker
Index dividend policy
Replication method
Replication model

Issuer

VIRTUS Investment Partners
VIRTUS Investment Partners ID Card
Number of funds
23
Total AuM
€2.42B
Expense ratio range
0.25% - 9.86%
Average expense ratio
0.9409%

Frequently asked questions about BBP

What does Virtus LifeSci Biotech Products ETF, BBP, invest in?

BBP is a Passive ETF. This ETF provides exposure to Equally Weighted US Equities.

Which benchmark or index does BBP replicate?

BBP tracks the LifeSci Biotechnology Products Total Return Index - USD, through a full replication replication method.

What is the Total Expense ratio (TER) of BBP?

BBP carries a total expense ratio (TER) of 0.79%, indicating the annual cost for holding the fund.

When was BBP launched?

BBP was introduced to the market on December 16, 2014. It trades on United States

Who is the ETF issuer of BBP?

Virtus LifeSci Biotech Products ETF, BBP, is provided by VIRTUS Investment Partners. Learn more about VIRTUS Investment Partners here.

What is the current assets under management (AUM) of BBP?

BBP oversees €68M in assets as of June 12, 2026.

How has BBP performed lately?

Based on data from June 12, 2026, BBP returned -1.38% over the past month, 7.00% over the last three months and 9.25% year-to-date.

What are the latest inflows or outflows for BBP?

As of June 12, 2026, BBP recorded net flows of +€3.7M over the last month and +€25M year-to-date.

Does BBP distribute dividends?

BBP follows a distributing dividend policy, meaning it pays out income to investors.

What are the main country or region exposures of BBP?

As of April 30, 2026, BBP has significant geographic allocations in USA, United Kingdom and Canada.

In which sector or theme does BBP invest in?

As of April 30, 2026, BBP focuses largely on Health Care.

How many securities does BBP hold and how diversified is it?

As of April 30, 2026, BBP holds 59 positions in its portfolio, with 45.32% of assets concentrated in its top 15 holdings.

What are the main positions in BBP?

As of April 30, 2026, BBP top three holdings include ARROWHEAD PHARMACEUTICALS INC, GB00BRXB0C07 and BIOGEN INC.

What is the base currency of BBP?

The base currency of BBP is USD.

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight